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CXCL8 in the NOD1 shRNA-expressing
cells is mediated by such receptors.
In summary, to our knowledge this is
the first report demonstrating that the
intracellular receptor NOD1 is func-
tional expressed in human keratino-
cytes, suggesting that NOD1 may be
involved in cutaneous innate immunity.
Further studies are needed to under-
stand the contribution of intracellular
innate immune receptors to cutaneous
host defense.
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TO THE EDITOR
Mutations in the gene encoding filag-
grin (FLG) were identified as the under-
lying cause of ichthyosis vulgaris (IV;
OMIM #146700) and also shown to
predispose to atopic dermatitis (AD;
Palmer et al., 2006; Smith et al., 2006).
Although FLG is considerably difficult
to analyze because of its large size
(412 kb) and highly repetitive nature,
PCR strategy that permits routine and
comprehensive sequencing of the entire
FLG has been developed recently
(Sandilands et al., 2007).
Using this methodology, we have
identified four prevalent FLG mutations
in Japanese patients with IV (Nomura
et al., 2008). We also demonstrated that
FLG mutations were significantly asso-
ciated with AD and the frequency of
these FLG mutations observed in our
Japanese AD cohort was about 20%.
However, the frequency in our cohortAbbreviations: AD, atopic dermatitis; FLG, filaggrin; IV, ichthyosis vulgaris
1302 Journal of Investigative Dermatology (2009), Volume 129
T Nomura et al.
Filaggrin Gene Mutations in Japanese
hetero wt homo
wt for S1695X homo for Q1701X hetero for S1695X wt for Q1701X
∗∗
∗
heterohetero
I
II
S100 calcium-binding domain
B domain FLG repeats C-terminal domain
Imperfect FLG repeats
S3296X
S2889XS2554X
Q1701X
S1695XR501XJapanese
FLG
441delA
2282del4
1249delG
3702delG 6867delAG
Q2147X
5360delG
R1474X
R501X
E2422X
7267delCA
R2447X
7945delA
11029delCA
S3247X
11033del4
Q3683X
R4307X
Europeans
and
Singaporean
3321delA
1 2 3 4 5 6 7 8-1 8-2 9 10-1 10-2
Figure 1. Clinical features and results of mutation analysis. (a) Fine scaling clearly visible on the proband’s leg. (b, c) He also showed marked palmoplantar
hyperlinearity. (d) A family tree of the ichthyosis vulgaris family shows the semidominant inheritance pattern. Solid symbols refer to the marked ichthyosis
vulgaris presentation; cross-hatched symbols refer to the milder ichthyosis vulgaris presentation. In addition, the proband, his mother, and sister had concomitant
dermatologist-diagnosed atopic dermatitis (*). wt, wild type for Q1701X; hetero, heterozygous; homo, homozygous. (e, f) A homozygous transition mutation
c.5101C4T was identified in the proband, resulting in Q1701X. A heterozygous transition mutation c.5084C4G was identified in one Japanese individual in
the control population, resulting in S1695X. Mutation S1695X is located only six amino acids upstream from Q1701X. (g) Loss-of-function FLG mutations are
shown in a schematic of profilaggrin. Mutations shown in red are prevalent; those in black are rare. Some individuals have duplication of the 8th and/or 10th
filaggrin repeat(s). Duplicated filaggrin repeats are represented as 8-1, 8-2, 10-1, and 10-2.
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was still lower than that seen in analo-
gous European case series, where it is up
to 48% (Barker et al., 2007; Sandilands
et al., 2007). Furthermore, it was re-
ported that up to 37% of Japanese
patients with AD had concomitant IV
(Uehara and Hayashi, 1981; Uehara and
Miyauchi, 1984). Taken together, there
might be further prevalent FLG mutations
to be discovered in the Japanese popula-
tion. Here we have studied a further
Japanese family with IV and identified
two further FLG mutations.
A newly recruited Japanese family
with IV was studied. The proband, a
one-year-old Japanese boy, showed
marked scaly dry skin on the extensor
limbs and trunk (Figure 1a). Marked
palmoplantar hyperlinearity was also
evident (Figure 1b and c). A diagnosis
of IV was made from these clinical
observations. His mother and sister also
showed scaly dry skin and palmoplan-
tar hyperlinearity, but the clinical se-
verity was mild compared to the
proband (Figure 1d). Therefore, the
inheritance pattern seemed semidomi-
nant. The proband, his mother, and his
brother had concomitant AD.
The medical ethical committee at
Hokkaido University Graduate School
of Medicine approved all the studies.
The study was conducted according to
the Declaration of Helsinki Principles.
Participants or their legal guardians
gave their written informed consent.
Following informed consent, genomic
DNA from all family members was
extracted from peripheral blood ac-
cording to standard procedures.
Initially, all family members were
screened for five FLG mutations identi-
fied in Japanese population so far,
R501X, 3321delA, S2554X, S2889X
and S3296X, by restriction enzyme
digestion, fluorescent PCR, and direct
DNA sequencing as described pre-
viously (Nomura et al., 2007, 2008;
Hamada et al., 2008). However, all
individuals were wild type for these
variants. Thus, we carried out full
sequencing of the FLG as described
previously (Sandilands et al., 2007),
which led to the identification of a
previously unreported nonsense muta-
tion Q1701X in repeat 4 in the present
family (Figure 1e). The proband turned
out to be homozygous for this truncation
mutation and his non-consanguineous
parents and his sister heterozygous,
whereas his brother wild type (Figure
1d). It was also confirmed that they carry
no pathogenic mutations in the other
FLG repeats. Then, we screened 118
unrelated Japanese patients with AD and
134 unrelated Japanese control indivi-
duals for Q1701X by direct DNA
sequencing. The diagnosis of AD in our
case series was made by experienced
dermatologists, according to the AD
diagnostic criteria by Hannifin and
Rajka (1980). Notably, mutation
Q1701X was also identified in two
Japanese patients with AD (1.7%),
which brings the total number of recur-
rent FLG mutations so far identified in
Japanese population to five.
During the screening for Q1701X, we
identified another previously unreported
FLG mutation, S1695X, which is located
only six amino acids upstream from
Q1701X, in the general Japanese control
population (Figure 1f). We screened 33
Japanese patients with IV and 118 with
AD for S1695X, but all patients were
wild type for this mutation. Only one
heterozygote was identified in the control
population. Therefore, S1695X seems to
be an extremely rare FLG mutation
in Japanese individuals. The control
individuals had not been examined in
relation to AD or IV status, that is, they
were population controls rather than
‘‘hypernormal’’ controls, so no clinical
details about the individual carrying
S1695X are available. In total, there are
at least seven FLG variants in the
Japanese population, including five that
are prevalent and two that are quite rare.
The FLG genotype data in the
Japanese AD case series and ethnically
matched population control series are
summarized in Table 1. In this study,
case–control association analyses were
performed by using Pearson’s r2 statistics,
as previously described (Palmer et al.,
2006). All alleles were observed to be in
normal Hardy–Weinberg equilibrium.
Here we demonstrate that about 25%
of patients in our Japanese AD case
series carry one or more of these seven
FLG mutations (combined minor allele
frequency¼0.127, n¼236) and these
variants are also carried by 4% of general
Japanese control individuals (com-
bined minor allele frequency¼ 0.019,
n¼ 268). There is significant statistical
association between the seven FLG
mutations and AD (r2 P¼1.75106).
Moreover, AD was manifested in hetero-
zygous carriers of these FLG mutations
with a Fisher’s exact test odds ratio
for AD of 6.8 (95% CI 2.5–18.5,
P¼ 3.7105), implying a causal rela-
tionship between FLG mutations and
AD. Taken together, these data strongly
suggest that skin barrier impairment
because of reduced filaggrin expression
is important in the pathogenesis in AD.
To date, 24 FLG mutations, including
the two identified in this study, have
been reported in the European, Japanese,
and Singaporean populations (Sandi-
lands et al., 2007; Chen et al., 2008;
Nomura et al., 2008). Interestingly,
Table 1. Atopic dermatitis case–control association analysis for FLG null variants in Japan
R501X 3321delA S1695X Q1701X S2554X S2889X S3296X Combined
Genotypes Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases
AA 134 118 133 113 133 118 134 116 133 112 132 105 134 114 129 91
Aa 0 0 1 5 1 0 0 2 1 6 2 13 0 4 5 24
aa 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3
Total 134 118 134 118 134 118 134 118 134 118 134 118 134 118 134 118
For combined genotype, r2 P=1.75 106; Fisher’s exact test odds ratio=6.8 (95% CI 2.5–18.5).
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mutations found in Japanese are different
from those found in Europeans and
Singaporean (Figure 1g), except in one
case of the common European R501X
mutation occurring as a very rare muta-
tion on a different haplotype in the
Japanese population (Hamada et al.,
2008). These observations imply that
every population is highly likely to have
a unique set of FLG mutations.
In conclusion, we have identified two
further FLG mutations in the Japanese
population. We also showed that at least
about 25% of Japanese patients with AD
carried one or more of FLG mutations.
As we have sequenced more than 30
Japanese patients with IV, there is now
little possibility that further highly pre-
valent mutations underlie the Japanese
population. Taking the high frequency
(up to 37%) of concomitant IV in
patients with AD into account, however,
it is still possible that there might be
further multiple low-frequency FLG mu-
tations to be discovered in the Japanese
population. Further FLG mutation ana-
lysis will be necessary to understand the
more precise genetic architecture of
filaggrin-related AD in Japan.
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‘‘White’’ Nevi and ‘‘Red’’ Melanomas: Association with the
RHC Phenotype of the MC1R Gene
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TO THE EDITOR
In 2002, we reported on three patients
presenting with melanocytic nevi lack-
ing pigmentation, which we named
‘‘white’’ dysplastic melanocytic nevi
(DMN) due to their peculiar clinical
appearance of white to pale red ma-
cules with accentuated skin markings
and a silvery ‘‘shining’’ when observed
with tangential light (Zalaudek et al.,
2002). Notably, all three patients had
melanoma, and in one patient white
DMN were associated with two pri-
mary amelanotic melanomas (AMMs).
We present herein a 25-year-old
woman (skin type I, red hair, and blue
eyes), who sought consultation for a
mole check. Clinical examination re-
vealed, besides approximately 30
slightly atypical light brown nevi onAbbreviations: AMM, amelanotic melanoma; DMN, dysplastic melanocytic nevi; RHC, red hair color
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